Birth Defects and Developmental Disabilities - Prevention and Surveillance
Active
- Assistance listing
- 93.073
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- 159 $278,584,490 in federal obligations
Program facts
- Assistance type
-
- Cooperative Agreement
- Treasury account
-
- 75-0958-1-1-550
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The CDC's Centers for Disease Control and Prevention (NCBDDD) awards grants under CFDA 93.073 for birth defects prevention and surveillance, with the most recent award disbursed August 1, 2021, and multiple opportunities currently open for 2026 applications.
The program funds population-based surveillance systems tracking birth defects and developmental disabilities across the lifespan, prevention research on specific conditions including congenital heart defects, neural tube defects, and fetal alcohol spectrum disorders, health promotion and evidence-based educational programs targeting patients and healthcare providers, and capacity-building activities such as epidemiological training fellowships and data modernization initiatives. Recent awards span surveillance of congenital heart defects in multiple states, implementation of alcohol screening and brief intervention in clinical settings to prevent prenatal alcohol exposure, dissemination of evidence-based information on ADHD and Tourette syndrome, and longitudinal birth defects research examining medication and infectious disease exposures during pregnancy.
All awards are Cooperative Agreements, representing 100 percent of the 159 grants awarded since 2010. The CDC's National Center on Birth Defects and Developmental Disabilities is the sole funding source. Combined federal dollars obligated total $278.6 million, with non-federal cost-share adding $6.8 million, reflecting discretionary matching in some projects. Award magnitudes vary significantly—recent examples include a $58.6 million five-year award for health promotion programs serving people with mobility disabilities, a $9.3 million award on Tourette syndrome education, and multiple state-level surveillance projects ranging from $3.7 million to $8.4 million over similar periods. Award frequency has declined markedly: 60 awards in 2016, but only one in 2021, suggesting reduced activity or a shift in funding strategy.
Three opportunities posted in 2026 signal program reactivation. CDC-RFA-DD-27-0065 (posted August 17, 2026) solicits cooperative agreements for birth defects and stillbirth surveillance with data modernization via electronic case reporting; CDC-RFA-DD-27-0028 (posted July 24, 2026) funds maternal-child health surveillance addressing fetal alcohol spectrum disorders, neonatal abstinence syndrome, and cytomegalovirus, with Component A requiring public health authority and legal access to clinical data. A December 2025 opportunity (CDC-RFA-DD-26-0222, due October 26, 2026) seeks cooperative agreements for long-term health outcomes surveillance in spina bifida, with two components supporting longitudinal data collection and protocol development for urologic management in infants and young children.
Eligible applicants include state and local health departments, universities, tribal governments, nonprofits, and some for-profit organizations. Project periods run 1 to 5 years, with awards typically supporting the first 12-month budget period explicitly and indicating recommended support for the remainder. Cooperative agreements carry requirements for satisfactory progress documentation and non-competitive continuation eligibility where funds allow.
Objective and description
- Objective
To work with State health agencies, universities, and public and private nonprofit organizations in planning, implementing coordinating or evaluating programs, research or surveillance activities related to improved birth outcomes, prevention of birt
- Description
To work with State health agencies, universities, and public and private nonprofit organizations in planning, implementing coordinating or evaluating programs, research or surveillance activities related to improved birth outcomes, prevention of birth defects, and the improvement of infant and child health and developmental outcomes. To provide a national, State or local focus for the prevention of conditions of persons with birth defects; to employ epidemiological methods to set priorities, build capacity and direct health promotion interventions for persons with birth defects; to expand public health training opportunities through fellowships to introduce geneticists, epidemiologists, and clinicians to public health practice through education, training and career-enhancing experiences. To enhance surveillance and research for birth defects; to prevent congenital heart defects and other major birth defects associated with medication use during pregnancy; to advance neural tube defect prevention; and enhance the quality and usefulness of newborn screening data and programs.
Eligibility
- Applicant eligibility
Full and open competition
- Beneficiary eligibility
State; Consumer; Local; Public nonprofit institution/organization; Federally Recognized Indian Tribal Governments; Individual/Family; Private nonprofit institution/organizations and others.
- Uses of assistance
Funds may be used to strengthen, to expand, to build upon or to enhance research, surveillance, health promotion, education, prevention/intervention activities that contribute to the mission and activities of the Division of Birth Defects and Infant Disorders. Funds may be used to improve and strengthen State and local public health infrastructure by providing technical assistance to other appropriate health agencies, organizations, special groups or coalitions. Funds may be used to support capacity building, program planning, development, implementation, evaluation, and surveillance for birth defects, infant and child health and developmental outcomes, including related health promotion, education and training, prevention/intervention. Funds may also be used to coordinate the dissemination of prevention information to the general public, target populations and among state and local agencies and public and private sector organizations in the United States. Funds may not be used for direct curative or rehabilitative services.
- Use restrictions
Funds may not be used for direct curative or rehabilitative services.
- Length and time phasing of assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.
How to apply
- Criteria for selecting proposals
In general, applications are reviewed on the basis of scientific/technical merit, with attention given to such matters as: (1) The degree to which the applicant satisfies the essential requirements and possesses other desired characteristics, such as depth, breadth, and merit of the overall application relative to the types of projects proposed; (2) clarity of purpose and overall qualifications, adequacy and appropriateness of personnel to accomplish proposed prevention research projects and demonstration projects, and the nation's health priorities and needs; (3) ability to generalize, translate and disseminate to State or local health departments, and other appropriate national regional, and local public health agencies and organizations; (4) reasonableness of the proposed budget in relation to the work proposed.
- Award procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.
- Renewals
Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government. If additional support is desired to continue a project beyond the approved project period, an application for competing continuation must be submitted for review in the same manner as a new application. Projects are renewable for periods of 1 to 4 years.
Grant opportunities
Show all 45
Grant awards
Latest 10 of 159 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | University Of Alabama At Birmingham | $52,641,760 | 19% |
| 2 | University Of North Carolina At Chapel Hill | $16,677,089 | 6% |
| 3 | Massachusetts Department Of Public Health | $14,227,938 | 5% |
| 4 | University Of Wisconsin System | $10,794,093 | 4% |
| 5 | Tourette Association Of America Inc. | $9,399,504 | 3% |
| 6 | The Johns Hopkins University | $8,871,802 | 3% |
| 7 | University Of South Carolina | $8,813,405 | 3% |
| 8 | Chadd, Inc. (Children & Adults With Attention-Deficit / Hyperactivity Disorder) | $7,650,000 | 3% |
| 9 | University Of Alaska Anchorage | $7,463,197 | 3% |
| 10 | Emory University | $7,174,105 | 3% |
10 of 95 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2026 | $752,326 |
| FY2025 | -$31 |
| FY2024 | $42,074,108 |
| FY2023 | $75,422,010 |
| FY2022 | $49,197,403 |
| FY2021 | $25,279,198 |
| FY2020 | $34,119,931 |
| FY2019 | $28,901,590 |
| FY2018 | $20,588,171 |
| FY2017 | $28,001,840 |
| FY2016 | $40,129,957 |
| FY2015 | $22,324,371 |
| FY2014 | $16,894,784 |
| FY2013 | $12,836,960 |
| FY2012 | $12,173,484 |
| FY2011 | $6,951,674 |
| FY2010 | $185,000 |
Show all 17
Quick answers
What is Assistance Listing 93.073?
Assistance Listing 93.073 is Birth Defects and Developmental Disabilities - Prevention and Surveillance, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).
What is the CFDA number for Birth Defects and Developmental Disabilities - Prevention and Surveillance?
Its CFDA number is 93.073: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.073 awarded?
159 grant awards under 93.073 have obligated $278,584,490 in federal funds to 95 recipients.
Who receives the most funding from 93.073?
The recipients obligated the most under Birth Defects and Developmental Disabilities - Prevention and Surveillance are University Of Alabama At Birmingham ($52,641,760), University Of North Carolina At Chapel Hill ($16,677,089) and Massachusetts Department Of Public Health ($14,227,938).
How much did 93.073 obligate in fiscal year 2025?
Grants under 93.073 obligated -$31 in federal funds in fiscal year 2025.
Are there open grant opportunities under 93.073?
4 listed opportunities under 93.073 are open or forecasted. The latest, Surveillance and Case Control Study of Stillbirth and Birth Defects (SUCCSSBD), was posted on August 17, 2026.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program